AGP

Artia Global Partners Portfolio holdings

AUM $389M
1-Year Est. Return 34.68%
This Quarter Est. Return
1 Year Est. Return
+34.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$389M
AUM Growth
+$47.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$43.7M
2
+$36.9M
3
+$36.5M
4
TRVI icon
Trevi Therapeutics
TRVI
+$7.18M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.6M

Top Sells

1
+$50M
2
+$29M
3
+$17.2M
4
ACLX icon
Arcellx
ACLX
+$15M
5
MRUS icon
Merus
MRUS
+$6.73M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
1
DELISTED
Verona Pharma
VRNA
$87.4M 21.03%
924,204
+385,716
INSM icon
2
Insmed
INSM
$34.9B
$75.8M 18.23%
752,712
+434,473
ARGX icon
3
argenx
ARGX
$51.4B
$43.2M 10.39%
78,311
+67,000
SLNO icon
4
Soleno Therapeutics
SLNO
$3.57B
$41.4M 9.97%
494,424
-4,049
LLY icon
5
Eli Lilly
LLY
$717B
$23.9M 5.76%
30,700
-64,187
BSX icon
6
Boston Scientific
BSX
$148B
$16.7M 4.01%
155,200
+25,500
MRUS icon
7
Merus
MRUS
$7.17B
$15.6M 3.76%
296,750
-127,890
DGX icon
8
Quest Diagnostics
DGX
$20.6B
$14.7M 3.53%
81,717
+25,000
AZN icon
9
AstraZeneca
AZN
$258B
$13.3M 3.21%
190,752
TRVI icon
10
Trevi Therapeutics
TRVI
$1.3B
$7.18M 1.73%
+1,311,840
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$62.1B
$6.84M 1.65%
20,970
-7,630
REGN icon
12
Regeneron Pharmaceuticals
REGN
$61.4B
$5.6M 1.35%
+10,671
SRRK icon
13
Scholar Rock
SRRK
$2.71B
$4.47M 1.08%
126,285
-45,900
RVMD icon
14
Revolution Medicines
RVMD
$10B
$3.83M 0.92%
104,190
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
$3M 0.72%
63,930
+10,000
EYPT icon
16
EyePoint Pharmaceuticals
EYPT
$954M
$2.98M 0.72%
316,700
ABBV icon
17
AbbVie
ABBV
$409B
$2.69M 0.65%
+14,500
VKTX icon
18
Viking Therapeutics
VKTX
$3.71B
$2.56M 0.62%
96,479
+6,200
ASND icon
19
Ascendis Pharma
ASND
$12.1B
$2.11M 0.51%
12,240
+4,800
TGTX icon
20
TG Therapeutics
TGTX
$5.59B
$1.96M 0.47%
54,515
VRTX icon
21
Vertex Pharmaceuticals
VRTX
$109B
$1.96M 0.47%
+4,400
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$3.29B
$1.52M 0.37%
+41,830
UTHR icon
23
United Therapeutics
UTHR
$19.1B
$1.44M 0.35%
5,000
MREO
24
Mereo BioPharma
MREO
$339M
$1.29M 0.31%
475,361
+54,002
PTGX icon
25
Protagonist Therapeutics
PTGX
$4.67B
$1.27M 0.31%
22,951
-310,900
1
2